Content about Menstrual cycle

May 6, 2013

Swiss Precision Diagnostics unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here.

NEW ORLEANS — Swiss Precision Diagnostics on Monday unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here. The latest home pregnancy test kit not only tells a woman if she is pregnant but also estimates the number of weeks since ovulation. 

May 3, 2013

Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

SAN DIEGO — Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

The study, scheduled for presentation to reporters at the American Urological Association's annual scientific meeting in San Diego on Tuesday, was conducted by researchers at New York University and the Waitemata District Health Board in Auckland, New Zealand, compared CPPS in young women who used oral contraceptives with the condition in those who didn't.

April 9, 2013

Procter & Gamble launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company.

CINCINNATI — Procter & Gamble on Tuesday launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company. And in support of the launch, former Dallas Cowboys cheerleader and veteran of ABC's "Dancing with the Stars" Melissa Rycroft will serve as spokeswoman. 

April 1, 2013

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

JERUSALEM — The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

The drug maker announced the approval of Quartette (levonorgestrel, ethinyl estradiol and ethinyl estradiol) tablets. Teva said the drug represented the "next generation" of extended-regimen oral contraceptives and was designed to minimize breakthrough bleeding between scheduled periods.

February 26, 2013

The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.

The agency announced the approval of Shionogi's Osphena (ospemifene) for women with moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause associated with declining levels of estrogen hormones.

February 25, 2013

In View, the Discovery Channel program of which Larry King is host, will include a feature about DivaCup, a reusable menstrual cup.

NEW YORK — In View, the Discovery Channel program of which Larry King is host, will include a feature about DivaCup, a reusable menstrual cup.

The show will air on March 7 at 7 a.m., examining the product and its role in feminine hygiene and featuring the mother and daughter who created it, Francine and Carinne Chambers. The product is made from healthcare-grade silicone and is designed to reduce the amount of disposable feminine hygiene waste created each year.

February 19, 2013

Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.

NEW YORK — Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.

January 8, 2013

The Electronic Retailing Self-Regulation Program recommended that Casper Labs modify or discontinue certain claims for Calmestra, a dietary supplement marketed as providing relief for symptoms of menopause, including claims that the product has been “clinically proven” to address symptoms of menopause.

NEW YORK — The Electronic Retailing Self-Regulation Program on Tuesday recommended that Casper Labs modify or discontinue certain claims for Calmestra, a dietary supplement marketed as providing relief for symptoms of menopause, including claims that the product has been “clinically proven” to address symptoms of menopause.

November 28, 2012

Regional life sciences association Biocom has introduced a new eco-friendly alternative to sanitary napkins and tampons. Enter FemmyCycle, a product from member FemCap.

SAN DIEGO — Regional life sciences association Biocom has introduced a new eco-friendly alternative to sanitary napkins and tampons. Enter FemmyCycle, a product from member FemCap.

The FemmyCycle was granted clearance by the U.S. Food and Drug Administration on Nov. 16. FemmyCycle creator Alfred Shihata is familiar with developing feminine products. His FDA-approved FemCap is one of the few hormone-free, woman-controlled contraceptive methods available.

September 21, 2012

The National Advertising Division on Thursday recommended that Church & Dwight discontinue its claim that the company’s First Response digital ovulation test is the “first and only test to predict ovulation based on your unique LH hormone level.”

NEW YORK — The National Advertising Division on Thursday recommended that Church & Dwight discontinue its claim that the company’s First Response digital ovulation test is the “first and only test to predict ovulation based on your unique LH hormone level.”

The claim, which appeared on product packaging and on the company’s website, was challenged by SPD Swiss Precision Diagnostics, the maker of the Clearblue DOT, a competing digital ovulation test product.

September 21, 2012

Comedic actresses Sherri Shepherd and Cloris Leachman are finding the humor in menopause by headlining the Poise brand’s Hot Flash Road Show, a free comedy tour making stops in New York and Los Angeles this fall that was announced Friday by Kimberly Clark.

DALLAS  — Comedic actresses Sherri Shepherd and Cloris Leachman are finding the humor in menopause by headlining the Poise brand’s Hot Flash Road Show, a free comedy tour making stops in New York and Los Angeles this fall that was announced Friday by Kimberly Clark. Open to the public, the Hot Flash Road Show is part of The 2nd Talk, an effort led by the Poise brand to start a whole new way to talk about menopause and help women approach this life stage with confidence.

June 29, 2012

The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.

FLORHAM PARK, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.

Shionogi, the U.S. division of Japanese drug maker Shionogi & Co., said Wednesday that the FDA had accepted for review its application for ospemifene, which the company touts as potentially the first oral alternative to vaginal estrogen treatments.

June 27, 2012

Intimina by Lelo, a line of intimate wellness products for women, on Monday showcased two new products from its second-generation collection of intimate care products for retailers in the pharmacy channel.

SAN JOSE, Calif. — Intimina by Lelo, a line of intimate wellness products for women, on Monday showcased two new products from its second-generation collection of intimate care products for retailers in the pharmacy channel.

May 9, 2012

Everett Labs on Monday announced the launch of Pregnitude, a dietary supplement that helps support ovulation function and menstrual cycle regularity for women who are interested in conceiving.

WEST ORANGE, N.J. — Everett Labs on Monday announced the launch of Pregnitude, a dietary supplement that helps support ovulation function and menstrual cycle regularity for women who are interested in conceiving.

March 16, 2012

Insight Pharmaceuticals has launched a mobile application for its E.P.T. brand.

LANGHORNE, Pa. — Insight Pharmaceuticals has launched a mobile application for its E.P.T. brand.

The new E.P.T. ovulation calculator features an easy-to-use interface that's designed to help users who are trying to get pregnant know when they are most fertile, or simply keep track of their menstrual cycle, the company said. The app — which currently is available for the iPhone, iPad, and iPod Touch, and supports Apple iOS 5 — also comes with 35 fertility tips and is equipped to provide email or calendar reminders on the day before expected ovulation.

March 15, 2012

The Food and Drug Administration has approved a drug that the manufacturer called the first oral contraceptive that also treats heavy menstrual bleeding.

WAYNE, N.J. — The Food and Drug Administration has approved a drug that the manufacturer called the first oral contraceptive that also treats heavy menstrual bleeding.

Bayer HealthCare Pharmaceuticals announced Wednesday the approval of Natazia (estradiol valerate and estradiol valerate and dienogest) tablets for heavy menstrual bleeding not caused by any conditions of the uterus. The drug was originally approved as an oral contraceptive in May 2010.

March 2, 2012

A generic drug maker has launched its version of an Abbott Labs drug.

JERUSALEM — A generic drug maker has launched its version of an Abbott Labs drug.

Teva Pharmaceutical Industries said it launched progesterone capsules in the 100-mg and 200-mg strengths, a generic version of Prometrium.

Prometrium is indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogen tablets. The drug also is indicated for use in secondary amenorrhea.

For the 12 months ended Jan. 31, Prometrium had sales of approximately $198 million, according to IMS Health data.

March 2, 2012

Watson has launched an authorized generic drug for treating postmenopausal women, the company said Friday.

PARSIPPANY, N.J. — Watson has launched an authorized generic drug for treating postmenopausal women, the company said Friday.

Watson announced the launch of progesterone capsules in the 100-mg and 200-mg strengths, an authorized generic version of Abbott Labs' Prometrium, under an agreement with Abbott. Abbott will manufacture the drug and supply it to Watson, which will market and distribute it and share profits. Other terms were not disclosed, the companies said.

August 10, 2011

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MIAMI — Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

May 25, 2011

Amerifit Brands on Wednesday launched its Azo PMS product, which has been formulated to help reduce moodiness, irritability and bloating with a variety of ingredients, including high-potency B vitamins, calcium, magnesium, folic acid and two natural herbal blends, the company stated.

CROMWELL, Conn. — Amerifit Brands on Wednesday launched its Azo PMS product, which has been formulated to help reduce moodiness, irritability and bloating with a variety of ingredients, including high-potency B vitamins, calcium, magnesium, folic acid and two natural herbal blends, the company stated.

May 23, 2011

Church & Dwight in April launched the First Response Digital Ovulation Test, a new at-home ovulation test that can detect a woman’s personal luteinizing hormone surge — the hormonal indication of ovulation — based on her own individual hormone levels.

PRINCETON, N.J. — Church & Dwight in April launched the First Response Digital Ovulation Test, a new at-home ovulation test that can detect a woman’s personal luteinizing hormone surge — the hormonal indication of ovulation — based on her own individual hormone levels.

April 27, 2011

Church & Dwight on Tuesday announced the launch of its First Response digital ovulation test, a new at-home ovulation test that can detect a woman's personal luteinizing hormone, or LH, surge — the hormonal indication of ovulation — based on her own individual hormone levels.

PRINCETON, N.J. — Church & Dwight on Tuesday announced the launch of its First Response digital ovulation test, a new at-home ovulation test that can detect a woman's personal luteinizing hormone, or LH, surge — the hormonal indication of ovulation — based on her own individual hormone levels.

February 14, 2011

The National Advertising Division of the Council of Better Business Bureaus last week recommended that SPD Swiss Precision Diagnostics, manufacturer of the Clearblue Easy Digital home pregnancy test, modify its advertising to clarify to consumers that the test only delivers completely “certain” results on or after the day of a consumer’s expected menstrual period.

NEW YORK — The National Advertising Division of the Council of Better Business Bureaus last week recommended that SPD Swiss Precision Diagnostics, manufacturer of the Clearblue Easy Digital home pregnancy test, modify its advertising to clarify to consumers that the test only delivers completely “certain” results on or after the day of a consumer’s expected menstrual period.

November 8, 2010

Procter & Gamble's feminine protection brand, Always, has launched its Always Me mobile application that...

CINCINNATI Procter & Gamble's feminine protection brand, Always, has launched its Always Me mobile application that enables women to track their period and ovulation.

Not just a standard period and ovulation tracker, the Always Me application is a personalized, on-the-go application that helps women manage their cycles and offers timely support and advice.

June 20, 2010

Drug maker Ferring Pharmaceuticals has launched a new treatment for women with cyclic heavy menstrual...